1Fisher A, Biggs CS, Start MS. Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase [ J ]. Amino Acids, 1998,14 ( 1-3 ) :43.
2Oertel WH, Quinn NP. Parkinsonism [ M ]. In : Brandt T, Caplan LR, Dichgans J, et al. Neurological disorders. Course and treatment. San Diego : Academic Press, 1996 : 715.
3Bennett VL, Juorio AV, Li XM. Possible new mechanism for the antiparkinsonian effect of amantadine [ J ]. J Psychiatry Neurosci, 1999,24( 1 ) :52.
8National Collaborating Centre for Chronic Conditions (UK). Parkinson' s Disease : National clinical guideline for diagnosis and management in primary and secondary care[M]. London (UK) : Royal College of Physicians,2006:237.
9Stewart DA. NICE guideline for Parkinson' s disease [ J ]. Age Ageing, 2007,36 (3) : 240.
10Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and pharmacological management of Parkinson' s disease. A national clinical guideline [ S ]. Edinburgh (Scotland):Scottish Intercollegiate Guidelines Network (SIGN) ,2010:61.
